Skip to content
healthcare.dev

Talzenna

NDC 63539-295, talazoparib, capsule, from U.S. Pharmaceuticals.

Product NDC
63539-295
Status
Listed
Labeler
U.S. Pharmaceuticals
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA211651
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/63539-295 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TALAZOPARIB TOSYLATE1 mg/1

Pharmacologic classes

Poly(ADP-Ribose) Polymerase Inhibitor [EPC]; Poly(ADP-Ribose) Polymerase Inhibitors [MoA]

Package NDCNDC-11Package
63539-295-30635390295301 BOTTLE in 1 CARTON (63539-295-30) / 30 CAPSULE in 1 BOTTLE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/13839d4f-6acf-4ffb-a128-79df59319273

Use it

Look up 63539-295 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/63539-295 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 63539-295. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.